Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • RNS System-New...

    RNS System-New treatment option for seizure control in refractory epilepsy

    Written by Medha Baranwal Baranwal Published On 2018-07-11T19:10:52+05:30  |  Updated On 11 July 2018 7:10 PM IST
    RNS System-New treatment option for seizure control in refractory epilepsy

    For patients of Refractory Epilepsy not responding to medication who had to resort to surgery earlier have a new option in RNS System for seizure control.


    A 27-year-old man, Richard Pollitt got relief from his continuously bothering seizures that sometimes lasted for five minutes through implantation of a small battery-powered device in his skull. Now, he rarely gets those seizures.


    Patients are diagnosed with refractory epilepsy when seizures do not respond to medication. For such patients, the next treatment option is surgery to remove the brain area causing the seizures. However, patients whose seizures originate on both sides of the brain are typically not candidates for this surgical option.


    “Traditional surgery wasn’t an option for Richard because removing tissue from both sides of the brain would have left him with no memory,” said Amit Verma, M.D., a Houston Methodist neurologist who specializes in epilepsy and seizures. “After considering a range of options, we decided that Richard would be a good candidate for a device that can help stop seizures from both regions of the brain.”


    Read Also: Deep Brain Stimulation approved for Refractory Epilepsy

    Responsive neurostimulation device or the RNS System treats patients with refractory epilepsy by continually observing and recording brain activity, recognizing abnormal signals, and producing small electrical pulses to stabilize brain activity and help stop seizures before physical symptoms appear. Developed by Neuropace, the system consists of a neurostimulator that is implanted into the skull and a remote that allows patients to wirelessly collect information for their physician. Once the device is turned on, it logs valuable data that allows physicians to track a patient’s treatment and improve care.


    “The data from the device shows that Richard has had only three seizures since the surgery in January,” Verma said. “That’s close to a 95 percent reduction rate in seizures, which is a remarkable improvement.”


    Pollitt’s mother, Peggy, said the surgery has given her son a fresh start in life and provided peace of mind to his family.


    “The device is so discreet that he can’t feel it,” Peggy said. “His medication doses have been reduced, he’s experienced increased energy levels and improved memory and clarity, and he rarely has seizures now. Any seizures he does have don’t last as long and aren’t nearly as severe as before.”


    Verma said there are very few patients, if any, who become completely seizure free with the RNS System. However, it has been proven an effective treatment in clinical studies as patients experienced a significant reduction rate in seizures that continued to improve over time.


    The device’s battery needs to be replaced every three to five years.

    BrainEpilepsyimplantable deviceneurosciencerefractory epilepsyResponsive neurostimulation deviceRichard PollittRNS systemseizuresskulltreatment
    Source : press release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok